| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af8d284777f42553da969d23c6337a7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9626ea705fee6e9b4755bbc05a704e78 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497 |
| filingDate |
2012-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb3b258aa57bbfa84e061eb4ba9abcb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b452229208ee1aafc4a706c92ed7a3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49f25c9c917157da4289005241f5938a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f1ad7dae74b232dee22ae2b51d6535b |
| publicationDate |
2014-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014309239-A1 |
| titleOfInvention |
Extended release formulation of a direct thrombin inhibitor |
| abstract |
Extended release formulations of 3-fluoro-2-pyridylmethyl-3-(2,2-difluoro-2-(2-pyridyl)ethylamino)-6-chloropyrazin-2-one-1-acetamide (DPOC-4088) that provide for better control of blood plasma levels. The extended release formulations maintain substantially constant plasma levels of the active ingredient for at least about 16 hours and provide for once-daily dosing. |
| priorityDate |
2011-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |